Insulinlike growth factor-binding protein proteolysis: An emerging paradigm in insulinlike growth factor physiology

Trends in Endocrinology and Metabolism

Volumn 8, Issue 8, 1997, Pages 299-306

  Fowlkes, John L ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; MATRIX METALLOPROTEINASE; SERINE PROTEINASE; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

CONFORMATIONAL TRANSITION; HORMONAL REGULATION; HUMAN; INSULIN LIKE ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0030678636     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(97)00112-4     Document Type: Review

References (54)

1. Andress DL, Birnbaum RS: 1992. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem 267:22,467-22,472.
2. Andress DL, Loop SM, Zapf J, Kiefer MC: 1993. Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells. Biochem Biophys Res Commun 195:25-30.
3. Angelloz-Nicoud P, Binoux M: 1995. Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF-binding protein-3 protease system in a human prostate cancer cell line (PC-3). Endocrinology 136:5485-5492.
4. Arai T, Arai A, Busby WH Jr, Clemmons DR: 1994. Glycosaminoglycans inhibit degradation of insulin-like growth factor-binding protein-5. Endocrinology 135:2358-2363.
5. Bach LA, Rechler MM: 1995. Insulin-like growth factor binding proteins. Diabetes Rev 3:38-61.
6. Baxter RC, Bayne ML, Cascieri MA: 1992. Structural determinants for binary and ternary complex formation between insulinlike growth factor-I (IGF-I) and IGF binding protein-3. J Biol Chem 267:60-65.
7. Booth BA, Boes M, Bar RS: 1996. IGFBP-3 proteolysis by plasmin, thrombin, serum: heparin binding, IGF binding, and structure of fragments. Am J Physiol 271:E465-E470.
8. Braulke T, Claussen M, Saftig P, et al.: 1995. Proteolysis of IGFBPs by cathepsin D-deficient mice. Prog Growth Factor Res 6:265-271.
9. Camacho-Hubner C, Busby WH Jr, McCusker RH, Wright G, Clemmons DR: 1992. Identification of the forms of insulin-like growth factor binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. J Biol Chem 267:11,949-11,956.
10. Campbell PG, Novak JF, Yanosick TB, McMaster JH: 1992. Involvement of the plasmin system in dissociation of the insulin-like growth factor-binding protein complex. Endocrinology 130:1401-1412.
11. Chernausek SD, Smith CE, Duffin KL, Busby WH, Wright G, Clemmons DR: 1995. Proteolytic cleavage of insulin-like growth factor binding protein 4 (IGFBP-4): localization of cleavage site to non-homologous region of native IGFBP-4. J Biol Chem 270: 11,377-11,382.
12. Cohen P, Graves HCB, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG: 1992. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab 75:1046-1053.
13. Cohen P, Peehl DM, Graves HCD, Rosenfeld RG: 1994. Biological effects of prostate specific antigen (PSA) as an IGF binding protein-3 (IGFBP-3) protease. J Endocrinol 14: 407-415.
14. 4 facilitates airway smooth muscle cell proliferation via modulation of the IGF axis. Am J Physiol 269:L151-L157.
15. Conover CA: 1995. Insulin-like growth factor binding protein proteolysis in bone cell models. Prog Growth Factor Res 6:301-309.
16. Conover CA, DeLeon DD: 1994. Acid-activated insulin-like growth factor binding protein-3 proteolysis in normal and transformed cells: role of cathepsin D. J Biol Chem 269:7076-7080.
17. Conover CA, Kiefer MC: 1993. Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells. J Clin Endocrinol Metab 76:1153-1159.
18. Conover CA, Kiefer MC, Zapf J: 1993. Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and -transformed human fibroblasts: insulin-like growth factor dependence and biological studies. J Clin Invest 91:1129-1137.
19. Conover CA, Durham SK, Zapf J, Masiarz FR, Kiefer MC: 1995a. Cleavage analysis of insulin-like growth factor (IGF)-dependent IGF-binding protein-4 proteolysis and expression of protease-resistant IGF-binding protein-4 mutants. J Biol Chem 270:4395-4400.
20. Conover CA, Perry JE, Tindall DJ: 1995b. Endogenous cathepsin D-mediated hydrolysis of insulin-like growth factor-binding proteins in cultured human prostatic carcinoma cells. J Clin Endocrinol Metab 80: 987-993.
21. Durham SK, Kiefer MC, Riggs BL, Conover CA: 1994. Regulation of insulin-like growth factor binding protein 4 by a specific insulin-like growth factor binding protein 4 proteinase in normal human osteoblast-like cells: implications in bone cell physiology. J Bone Miner Res 9:111-117.
22. Fielder PJ, Pham H, Adashi EY, Rosenfeld RG: 1993. Insulin-like growth factors (IGFs) block FSH-induced proteolysis of IGF-binding protein-5 (BP-5) in cultured rat granulosa cells. Endocrinology 133: 415-418.
23. Fielder PJ, Rosenfeld RG, Graves HCB, et al.: 1994. Biochemical analysis of prostate specific antigen-proteolyzed insulin-like growth factor binding protein-3. Growth Regul 4:164-172.
24. Fowlkes JL: 1994. Degradation of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) by a metal-dependent protease produced by human fibroblasts. Endocr J USA 2:63-68.
25. Fowlkes J, Freemark M: 1992. Evidence for a novel insulin-like growth factor (IGF)-dependent protease regulating IGF-binding protein-4 in dermal fibroblasts. Endocrinology 131:2071-2076.
26. Fowlkes JL, Serra DM: 1996. Characterization of glycosaminoglycan-binding domains present in insulin-like growth factor-binding protein-3. J Biol Chem 271:14,676-14,679.
27. Fowlkes JL, Enghild JJ, Suzuki K. Nagase H: 1994a. Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J Biol Chem 269:25,742-25,746.
28. Fowlkes JL, Suzuki K, Nagase H, Thailkill KM: 1994b. Proteolysis of insulin-like growth factor binding protein-3 during rat pregnancy: role for matrix metalloproteinases. Endocrinology 135:2810-2813.
29. Fowlkes JL, Serra DM, Rosenberg CK, Thrailkill KM: 1995a. Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) functions as an IGF-reversible inhibitor of IGFBP-4 proteolysis. J Biol Chem 270: 27,481-27,488.
30. Fowlkes JL, Thrailkill KM, Serra DM, Suzuki K, Nagase H: 1995b. Matrix metalloproteinases as insulin-like growth factor binding protein-degrading proteinases. Prog Growth Factor Res 6:255-263.
31. Fowlkes JL, Thrailkill KM, Carlos-George N, Rosenberg CK, Serra DM: 1997. Heparin-binding highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor binding proteins (IGFBPs) -3, -5 and -6 inhibit IGFBP-4 degradation. Endocrinology 138:2280-2285.
32. Giudice LC, Farrell EM, Pham H, Lamson G, Rosenfeld RG: 1990. Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperia: effects of a pregnancy-associated serum protease activity. J Clin Endocrinol Metab 71:806-816.
33. Grimes RW, Hammond JM: 1994. Proteolytic degradation of insulin-like growth factor (IGF)-binding protein-3 by porcine ovarian granulosa cells in culture: regulation by IGF-1. Endocrinology 134:337-343.
34. Hossenlopp P, Segovoa B, Lassarre C, Roghani M, Bredon M, Binoux M: 1990. Evidence of enzymatic degradation of IGFBPs in the 150 kD complex during pregnancy. J Clin Endocrinol Metab 71:797-805.
35. Jones JI, Clemmons DR: 1995. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34.
36. Kamyar A, Pirola Cj, Wang HM, et al.: 1994. Expression and insulin-like growth factor-dependent proteolysis of insulin-like growth factor-binding protein-4 are regulated by cell confluence in vascular smooth muscle cells. Circ Res 74:576-585.
37. Lalou C, Silve C, Rosato R, Segovia B, Binoux M: 1994. Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF binding protein-3 production and proteolysis in human osteosarcoma cells. Endocrinology 135:2318-2326.
38. Lalou C, Lassarre C, Binoux M: 1996. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. Endocrinology 137: 3206-3212.
39. Lassarre C, Binoux M: 1994. Insulin-like growth factor binding is protein-3 is functionally altered in pregnancy plasma. Endocrinology 134:1254-1262.
40. Menouny M, Binoux M, Babajko S: 1997. Role of insulin-like growth factor binding protein-2 and its limited proteolysis in neuroblastoma cell proliferation: modulation by transforming growth factor-β and retinoic acid. Endocrinology 138:683-690.
41. Myers SE, Cheung PT, Handwerger S, Chernausek SD: 1993. Insulin-like growth factor-I (IGF-I) enhanced proteolysis of IGF-binding protein-4 in conditioned medium from primary cultures of human decidua: independence from IGF receptor binding. Endocrinology 133:1525-1531.
42. Nam TJ, Busby WH Jr, Clemmons DR: 1994. Human fibroblasts secrete a serine protease that cleaves insulin-like growth factor-binding protein-5. Endocrinology 135: 1385-1391.
43. Nam TJ, Busby WH Jr, Clemmons DR: 1996. Characterization and determination of the relative abundance of the two types of insulin-like growth factor binding protein-5 proteases that are secreted by human fibroblasts. Endocrinology 137:5530-5536.
44. Oh Y, Nagalla SR, Yamanaka Y, Kim HS, Wilson E, Rosenfeld RG: 1996. Synthesis and characterization of insulin-like growth factor binding protein (IGFBP)-7: recombinant human mac25 protein specifically binds IGF-I and IGF-II. J Biol Chem 271: 30,322-30,325.
45. Parker A, Gockerman A, Busby WH Jr, Clemmons DR. 1995. Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth muscle cells. Endocrinology 136:2470-2476.
46. Parker A, Clarke JB, Busby WH Jr, Clemmons DR: 1996. Identification of the extracellular matrix binding sites for insulin-like growth factor-binding protein 5. J Biol Chem 271: 13,523-13,529.
47. Rajah R, Bhala A, Nunn SE, Peehl DM, Cohen P: 1995a. 7S nerve growth factor is an insulin-like growth factor-binding protein protease. Endocrinology 137:2676-2682.
48. Rajah R, Lorraine K, Nunn S, Solberg P, Beers T, Cohen P: 1995b. Insulin-like growth factor binding protein (IGFBP) proteases: functional regulators of cell growth. Prog Growth Factor Res 6:273-284.
49. Rajah R, Nunn SE, Herrick DJ, Grunstein MM, Cohen P:. 1996. Leukotriene D4 induces MMP-1, which functions as an IGFBP protease in human airway smooth muscle cells. Am J Physiol 271:L1014-L1022.
50. Rechler MM: 1993. Insulin-like growth factor binding proteins. Vitam Horm 47:1-114.
51. Rechler MM: 1995. Non-receptor-binding proteins for insulin-like growth factors and other cytokines: modulators of peptide action. In Weintraub BD, ed. Molecular Endocrinology: Basic Concepts and Clinical Correlations. New York, Raven Press, pp 155-180.
52. Salahifar H, Baxter RC, Martin JL: 1997. Insulin-like growth factor binding protein (IGFBP)-3 protease activity secreted by MCF-7 breast cancer cells: inhibition by IGFs does not require IGF-IGFBP interaction. Endocrinology 138:1683-1690.
53. Thrailkill KM, Quarles LD, Nagase H, Suzuki K, Serra DM, Fowlkes JL: 1995. Characterization of insulin-like growth factor-binding protein-5-degrading proteases produced throughout murine osteoblast differentiation. Endocrinology 136:3527-3533.
54. Wood WI, Cachianes G, Henzel WJ, et al.: 1988. Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein. Mol Endocrinol 2:1176-1185.